Showing results (1041-1050 of 6,501) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Levamisole regulates the proliferation of murine liver T cells through Kupffer-cell-derived cytokinesJ A Johnkoski, S M Peterson, R J Doerr, et al.Cancer Immunology, Immunotherapy : CII|December 1, 1996
Autoantibody to p185erbB2/neu oncoprotein by vaccination with xenogenic DNAA Concetti, A Amici, C Petrelli, et al.Cancer Immunology, Immunotherapy : CII|March 1, 1997
Antimetastatic effect of recombinant human macrophage-colony-stimulating factor against lung and liver metastatic B16 melanomaT Sakurai, M Yamada, S Simamura, et al.Cancer Immunology, Immunotherapy : CII|December 21, 2016
T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancerMohammad D Samy, Wei Lue Tong, John M Yavorski, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Increased bleomycin-induced chromosome damage in lymphocytes of patients with common variable immunodeficiency indicates an involvement of chromosomal instability in their cancer predispositionI Vorechovsky, M Munzarova, J LokajCancer Immunology, Immunotherapy : CII|April 11, 2014
miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signalingLin Miao, Kunmei Liu, Meijuan Xie, et al.Cancer Immunology, Immunotherapy : CII|March 27, 2014
Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacitySuneesh Kaimala, Yassir A Mohamed, Nancy Nader, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cellsF Vánky, G Stuber, S Rotstein, et al.Cancer Immunology, Immunotherapy : CII|May 9, 2014
Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapyClaudia Brehm, Sabine Huenecke, Ruth Esser, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Relative positions of some epitopes on carcinoembryonic antigenA Larsson, R Ghosh, S HammarströmPageof 651